首页|神经元特异性烯醇化酶、S-100b蛋白对体外心肺复苏患者神经功能预后的预测价值

神经元特异性烯醇化酶、S-100b蛋白对体外心肺复苏患者神经功能预后的预测价值

扫码查看
目的 探讨神经元特异性烯醇化酶(neuron-specific enolase,NSE)和S-100b蛋白对成人体外心肺复苏(extracorporeal cardiopulmonary resuscitation,ECPR)患者神经功能预后的预测价值.方法 收集2021年4月至2024年4月于南京医科大学第一附属医院急诊科接受ECPR治疗的心脏骤停(cardiac arrest,CA)患者,分别采集患者体外膜肺氧合(extracorporeal membrane oxygenation,ECMO)建立后24 h、48 h和72 h的外周静脉血,检测血清NSE和S-100b水平,并记录72 h内峰值进行分析,评价其对神经功能不良预后(CPC评分3~5分)的预测价值.结果 研究共纳入110例患者,预后不良患者81例,占73.6%.与预后良好组比较,预后不良组72 h内血清NSE和S-100b峰值水平显著升高(P<0.05).进一步将预后不良组分为CPC 3~4及CPC 5两组.结果 显示,CPC5组NSE、S-100b水平均显著高于其他两组,差异有统计学意义(P<0.05).CPC 1~2组NSE水平明显低于CPC 3~4组(P=0.048),而S-100b水平在两组间差异无统计学意义(P=0.143).多因素Logistic回归分析显示,NSE是ECPR患者神经功能预后不良的独立危险因素(OR=1.047,95%CI:1.018~1.077,P=0.001).ROC 曲线分析显示,72h 内 NSE(AUC=0.843,95%CI:0.770~0.915,P<0.001)和 S-100b(AUC=0.822,95%CI:0.739~0.905,P<0.001)峰值水平对ECPR患者神经功能不良预后具有预测价值,最佳阈值分别是60.14 µg/L和0.195 μ.g/L.结论 ECPR患者ECMO建立后72 h内血清NSE、S-100b峰值水平与神经功能不良预后具有相关性.
The predictive value of neuron-specific enolase and s-100b protein for neurological outcome in patients with extracorporeal cardiopulmonary resuscitation
Objective To evaluate the prognostic value of serum levels of neuron-specific enolase(NSE)and S-100b in extracorporeal cardiopulmonary resuscitation(ECPR)patients.Methods Cardiac arrest(CA)patients whose blood samples were collected at 24 h,48 h and 72 h after establishment of extracorporeal membrane oxygenation between April 2021 and April 2024 in Emergency Department of the First Affiliated Hospital of Nanjing Medical University were enrolled in this single-center study.The serum levels of NSE and S-l00b were measured,and their peak values within 72 h were used for further analysis.The neuro-prognostic values of these two indicators in predicting poor outcomes(Cerebral Performance Category 3-5)were analyzed.Results Among the 110 patients involved,81 cases(73.6%)were poor outcomes after ECPR treatment.In the poor-outcome group,serum peak levels of NSE and S-l00b were significantly increased(P<0.05).Furthermore,the poor-outcome group was divided into CPC 3-4 group and CPC 5 group.The levels of NSE and S-100b in CPC 5 group were significantly higher than those in CPC 1-2 and 3-4 groups(P<0.05).NSE levels were significantly lower in CPC 1-2 group than in CPC 3-4 group(P=0.048),while no significant differences of S-l00b levels were found between the two groups(P=0.143).Multivariate logistic regression analysis showed that NSE was an independent risk factor for poor outcomes in ECPR patients(OR=1.047,95%CI:1.018~1.077,P=0.001).ROC curve showed that peak levels of NSE(AUC=0.843,95%CI:0.770~0.915,P<0.001)and S-l00b(AUC=0.822,95%CI:0.739~0.905,P<0.001)within 72 h had predictive value for poor outcomes in ECPR patients,with optimal cut-off values of 60.14 μg/L and 0.195 μg/L,respectively.Conclusions The serum peak levels of NSE and S-l00b within 72 h after ECMO establishment in ECPR patients are correlated with poor neurological outcomes.

Extracorporeal membrane oxygenationCardiopulmonary resuscitationNeuron-specific enolase(NSE)S-100bPrognosis

王淦楠、张忠满、张华忠、梅勇、陈旭锋

展开 >

南京医科大学第一附属医院急诊科,南京 210029

体外膜肺氧合 心肺复苏 神经元特异性烯醇化酶 S-100b蛋白 预后

2024

中华急诊医学杂志
中华医学会

中华急诊医学杂志

CSTPCD北大核心
影响因子:1.556
ISSN:1671-0282
年,卷(期):2024.33(12)